Soleno Therapeutics (SLNO) Enterprise Value Growth (5y) (2018 - 2026)
Soleno Therapeutics (SLNO) Enterprise Value Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.77% |
| Dec 31, 2025 | -44.07% |
| Sep 30, 2025 | -54.80% |
| Jun 30, 2025 | -35.63% |
| Mar 31, 2025 | -80.65% |
| Dec 31, 2024 | -69.66% |
| Sep 30, 2024 | -87.01% |
| Jun 30, 2024 | -76.57% |
| Mar 31, 2024 | -50.46% |
| Dec 31, 2023 | -49.01% |
| Sep 30, 2023 | -38.62% |
| Jun 30, 2023 | -9.03% |
| Mar 31, 2023 | -195.61% |
| Dec 31, 2022 | -234.25% |
| Sep 30, 2022 | -255.06% |
| Jun 30, 2022 | -269.48% |
| Mar 31, 2022 | -22.42% |
| Dec 31, 2021 | -260.48% |
| Sep 30, 2021 | -39.09% |
| Jun 30, 2021 | -68.11% |